Organogenesis Holdings Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.84

-0.03 (-3.46%)

As of Nov 7, 2:03 AM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 4 57%

Sell 3 43%

Price Target

Analyst Price Target +894.2% upside

Low Target $5.30

Average Target $8.35

High Target $10.56

Current Price $0.84

Current
$0.84

Target
$8.35

$5.30 $8.35 avg $10.56

Scenario Analysis

Bear Case

$5.30

531.0%

Low target

Base Case

$8.35

+894.2%

Avg target

Bull Case

$10.56

+1,157.3%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$7.08

-88.1% from high

52-Week Low

$0.73

+15.1% from low

Target vs 52W High

$8.35

+18.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-11.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+117.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.9%
MRNA Moderna Inc	Hold	31	35%	$149.45	-41.2%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-54.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-40.7%